JASON SOBIESKI to Neoplasms
This is a "connection" page, showing publications JASON SOBIESKI has written about Neoplasms.
Connection Strength
0.059
-
Kinase-Inactivated EGFR Is Required for the Survival of Wild-Type EGFR-Expressing Cancer Cells Treated with Tyrosine Kinase Inhibitors. Int J Mol Sci. 2019 May 22; 20(10).
Score: 0.059